Novel polyurethane based particulate formulations of infliximab reduce inflammation in DSS induced murine model of colitis – A preliminary study-Reference-Cited by-同舟云学术

Novel polyurethane based particulate formulations of infliximab reduce inflammation in DSS induced murine model of colitis – A preliminary study

Published:2021-07 Issue: Volume:604 Page:120717
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Pabari Ritesh M.,Tambuwala Murtaza M.,Lajczak-McGinley Natalia,Aljabali Alaa,Kirby Brian P.,Keely Stephen,Ramtoola Zebunissa

Funder

Irish Research Council

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference65 articles.

1. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017;Alatab;LancetGastroenterol. Hepatol.,2020

2. Distinct cytokine patterns identified from multiplex profiles of murine DSS and TNBS-induced colitis;Alex;Inflamm Bowel Dis.,2009

3. Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases;Ali;J. Control. Release,2014

4. Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial;Almon;J. Clin. Gastroenterol.,2021

5. imager: an R package for image processing based on CImg;Barthelmé;J. Open Sour. Software,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lipid- and polymer-based formulations containing TNF-α inhibitors for the treatment of inflammatory bowel diseases;Drug Discovery Today;2024-08

2. Discovery of dibenzyl amide derivatives as novel CXCR4 modulators against inflammatory bowel disease;European Journal of Medicinal Chemistry Reports;2024-04

3. The state-of-art polyurethane nanoparticles for drug delivery applications;Frontiers in Chemistry;2024-02-26

4. Microbiota-sensitive drug delivery systems based on natural polysaccharides for colon targeting;Drug Discovery Today;2023-07

5. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments;Journal of Nanobiotechnology;2023-03-25